Status:
COMPLETED
Medication Adherence in Kidney Transplant Patients: SystemCHANGE™ Results of the Turkish MAGIC Randomized Clinical Trial
Lead Sponsor:
Dokuz Eylul University
Collaborating Sponsors:
The Scientific and Technological Research Council of Turkey
Conditions:
Medication Adherence
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The SystemCHANGETM intervention harnesses patients' established daily routines/habits, environment, and important others, as possible solutions that are reoccurring and thus reliable systems that coul...
Eligibility Criteria
Inclusion
- The inclusion criteria were patients having only kidney transplantation, aged 18 years or older, taking only immunosuppressant therapy twice daily, not staying in hospital and not diagnosed with a disease shortening their life span. They also were required to own a telephone, use an electronic medication cap and bottle, understand and speak Turkish, and have approval from their nephrologist to participate in the study. They were also assessed in person for cognitive impairment using the Standardized Mini Mental Test. Those who received a 23 or higher score on the test were enrolled in the study sample.
Exclusion
Key Trial Info
Start Date :
September 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2022
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT06106854
Start Date
September 16 2019
End Date
September 15 2022
Last Update
October 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yaprak Sarıgöl Ordin
Izmir, Turkey (Türkiye), 35240